Results 201 to 210 of about 4,051,537 (300)

Gut microbiota as a novel therapeutic target for eating disorders and obesity

British Journal of Pharmacology, EarlyView.
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė, Victor Mathis, Emmanuel Darcq, Aurelijus Burokas, Elena Martín‐García, Rafael Maldonado   +5 more
wiley   +1 more source

RETRACTED ARTICLE: The combined use of Angelica sinensis and fentanyl injection may cause serotonin syndrome: a case report. [PDF]

J Med Case Rep
Wang Q, Liu J, Duan J, Wu Y, Wu X, Chen Y.   +5 more
europepmc   +1 more source

Emerging insights into amino acid metabolism in the heart: implications for cardiovascular diseases and therapeutic targeting

British Journal of Pharmacology, EarlyView.
As a metabolically versatile organ, the heart is capable of generating energy from a wide range of substrates. Although fatty acid and glucose metabolism in the heart have been extensively studied, the contribution of amino acid metabolism to cardiac physiology and disease is gaining increasing attention.
Tayyiba Azam, Hongyuan Zhang, Min Zi, Chen Chen, Junfang Wu, Andreas Papapetropoulos, Xin Wang   +6 more
wiley   +1 more source

Case Report: Multiple Truama AND Serotonin Syndrome

Serotonin syndrome is a life-threatening condition that may be caused by an unanticipated interaction of serotonergic drugs, this produces excess serotonin in the central nervous system.
S, O. (Ojum)
core  

Cholinergic inputs to motoneurons in the spinal cord augment focal muscle spasticity in rodents

British Journal of Pharmacology, EarlyView.
Background and Purpose Cholinergic premotor inputs to motoneurons support high levels of motor output when required. However, the possible role of these inputs in pathologically elevated muscle tone has not been characterised. To address this, we examined the modulatory effect of spinal acetylcholine (ACh) on experimental spastic paralysis ...
Patrik Meglić, Petra Šoštarić, Eirini Tsape, Melpomeni Galani, Ana Knezović, Laura Restani, Marco Pirazzini, Ornella Rossetto, Gareth B. Miles, Laskaro Zagoraiou, Ivica Matak   +10 more
wiley   +1 more source

Cocaine-Induced Rhabdomyolysis With Acute Kidney Injury in the Absence of Serotonin Syndrome: A Case Report. [PDF]

Cureus
Adiat M, Nafees S, Kumar V, Abdelfattah M, Javeed A, Anwar MM, Zamari K, Riasat MH, Chohan MT.   +8 more
europepmc   +1 more source

Depressive and Anxiety Symptoms in Vestibular Migraine and Probable Vestibular Migraine

Clinical Otolaryngology, EarlyView.
ABSTRACT Introduction It has been previously reported that patients with vestibular migraine (VM) are more prone to anxiety and depressive symptoms. However, the association between the pathophysiology of VM and anxiety and depressive symptoms is still unclear.
Chisato Fujimoto, Naoko Ogata, Kento Koda, Kentaro Ichijo, Mineko Oka, Makoto Kinoshita, Kenji Kondo   +6 more
wiley   +1 more source

Time Course of Serum Dextromethorphan Concentrations in a Case of Serotonin Syndrome After Massive Overdose. [PDF]

Am J Case Rep
Yamada S, Taniguchi H, Terayama T, Hayakawa A, Toda H, Abe H, Kiyozumi T.   +6 more
europepmc   +1 more source

Novel targets in headache: A narrative review

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This narrative review summarizes novel applications for the use of calcitonin gene‐related peptide (CGRP)‐targeted therapies that go beyond migraine, the latest updates with respect to targeting pituitary adenylate cyclase‐activating peptide (PACAP) as therapeutic in migraine, as well as exploring other more recently ...
Adriana Della Pietra, Peter J. Goadsby, Carolina Oldoni, Stephen Silberstein, Fred Cohen, Simon Akerman   +5 more
wiley   +1 more source

Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a Pediatric Patient Receiving Fluoxetine and Haloperidol: A Case Report. [PDF]

J Pediatr Pharmacol Ther
Aráez PMB, Turner S.
europepmc   +1 more source